Our news

Med City News Medical chatbots have the potential to shape the future of healthcare data retrieval and decision-making support. But this can’t become a reality unless precautions are taken to make sure the answers are both grounded in reality and extracted from reliable sources. Chatbots have come a long way since inception. While we’ve long […]

Swiss Biotech Biotech is the key growth area for pharma and life sciences, and Swiss-based biotech companies play a major role across the entire development cycle, from their share of the pipeline, to clinical trial activity, to the emerging commercialization of new molecules. Switzerland’s ability to drive and nurture innovation is continuing to expand. Emerging […]

BMC – BioMed Central Ltd Background The expectations of the informed consent process for participants in a clinical trial are well documented in ICH-Good Clinical Practice, The Declaration of Helsinki 1964 and “The Medicines for Human Use (Clinical Trials) Regulations 2004 (as amended)”. For Clinical Trials of Interventional Medicinal Products (CTIMPs), these expectations can be […]

Med City News A few years ago, some colleagues and I were discussing the implications of the “post-EHR” world, where everyone has electronic health records and, with the pending mandates of the 21st Century Cures Act, systems would soon be required to share data. This discussion arose from the ongoing issue that clinicians still struggle […]